VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1791362
Sex: M
Age:
State: SC

Vax Date: 02/04/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Facial eczema in remission for many years, resurfaced after the second dose of vaccine; This is a spontaneous report from a contactable Physician (patient). A 49-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EN9581) via unknown route administered in Arm Left on 04Feb2021 (at the age of 49 years old) as dose 2, single for COVID-19 immunisation. The patient medical history included Facial eczema. The patient did not have allergies. The concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: El3246) via unknown route administered in Arm Left on 13Jan2021 at 01:00 PM (at the age of 49 years old) as dose 1, single for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. On 18Feb2021 at 01:00 PM, the patient experienced Facial eczema in remission for many years, resurfaced after the second dose of vaccine. Patient did not receive treatment for the event. The patient did not have covid prior vaccination and not tested for covid post vaccination. The outcome was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness: Eczema facial (H/o (History of) Facial eczema in remission for many years)

ID: 1791363
Sex: F
Age:
State: TX

Vax Date:
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Sore arm; This is a spontaneous report from a contactable consumer (patient, reported for self). A 54-year-old (non-pregnant) female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number and expiry date: unknown), dose 2 via an unspecified route of administration, administered in left arm on an unspecified date as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not pregnant at the time of vaccination. The patient had earlier received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: Not reported) via via an unspecified route of administration, administered in left arm (reported as) on 31Jan2021 at 12:00 (at the age of 54-years-old) for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. On 20Feb2021 13:30, the patient experienced sore arm. Felt as if punched in the arm. Even hurt when not using arm. By 22Feb, arm only hurt when using it. Much less sore. Patient received no treatment for the event. Post vaccination, the patient was not tested for COVID-19. The outcome of event was recovering. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1791364
Sex: M
Age:
State: KS

Vax Date: 02/17/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: fatigue; general malise; Chills; body ache; headache; slept appx. 19 out of 24 hours per day; This is a spontaneous report from a contactable consumer(patient). A 49-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: Not Reported, Expiry Date: Not Reported), via an unspecified route of administration, administered in Arm Left on 17Feb2021 (at the age of 49-year-old) at 17:15 as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included clonazepam (CLONAZEPAM) taken for an unspecified indication, start and stop date were not reported; allopurinol (ALLOPURINOL) taken for an unspecified indication, start and stop date were not reported; sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. It was unknown if the patient was diagnosed with covid prior vaccination. The patient was not tested for covid post vaccination. On 17Feb2021 at 18:30, the patient experienced fatigue, general malaise. On an unspecified date in feb2021 that is on days two and three, the patient experienced chills, body aches, headache, slept appx. 19 out of 24 hours per day. On day four, there was a slight improvement, slept 16 out of 24 hours. On day five, the adverse event improved, but still feeling about 70% well. The patient did not receive any treatment for the reported event. Outcome of the events was recovered with sequelae. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds: CLONAZEPAM; ALLOPURINOL; ZOLOFT.

Current Illness:

ID: 1791365
Sex: F
Age:
State: GA

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: First vaccine - tenderness in injection site; A 67-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3246) via an unspecified route of administration, administered in right arm on 20Jan2021 10:15 (at the age of 67-year-old) as dose 1, single for COVID-19 immunisation. Patient was not pregnant at the time of vaccination. Medical history included Irritable bowel syndrome and osteoporosis from an unknown date and unknown if ongoing. Concomitant medication included tetanus vaccine taken for an unspecified indication on 22Jan2021. Patient received any other vaccines within 4 weeks prior to the COVID vaccine. Patient received other unspecified medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. No Covid prior vaccination. Since the vaccination, the patient had been tested for COVID-19. On an unspecified date, patient experienced tenderness at the injection site. No treatment received for the adverse event. Outcome of the event was resolved with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791366
Sex: F
Age:
State: SC

Vax Date:
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: bad jaw pain; This is a spontaneous report from a contactable consumer who reported for a female (patient). A adult female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration date not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was unknown if patient was pregnant at the time of vaccination. Allergies to medications, food, or other products was unknown. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine and any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, was the patient diagnosed with COVID-19 was unknown. It was unknown if the patient been tested for COVID-19 since the vaccination.The patient experienced really bad jaw pain on an unknown date in Feb2021. It was unknown if patient received treatment for the adverse event. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791367
Sex: F
Age:
State: IL

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Reported her daughter had a tender shoulder after her first COVID-19 Vaccine dose; This is a spontaneous report from a contactable consumer or other non-healthcare professional (parent). A 35-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date in Jan2021 (age at the time of vaccination was 35 years) as DOSE 1, SINGLE for covid-19 immunization at Clinic. The patient medical history, concomitant medications and other products were not reported. On an unspecified date in 2021, the reporter(s) her daughter had a tender shoulder after her first covid-19 vaccine dose. The reporter clarified her daughter's shoulder was tender enough to wake her up at night was she laid on her shoulder. It was reported her daughter got her COVID-19 Vaccine from the Health Department and stated that her daughter was a clinical psychologist. She said her daughter received her first COVID-19 Vaccine dose within the first 3 weeks of giving the COVID-19 Vaccine out. It was reported her daughter's shoulder tenderness lessened over the following days, and in 2-3 days her daughter's tender shoulder was gone. It was reported that as maybe her daughter took the same brand Ibuprofen she used (Equiline Brand) because she had seen a bottle of Equiline Brand Ibuprofen at her daughter's house. The reporter said she did not have the Ibuprofen NDC, Lot, and Expiration Date. The outcome of the event was recovered on an unspecified date in 2021. No follow-up attempts are possible. Information on lot number, batch number could not be obtained.

Other Meds:

Current Illness:

ID: 1791368
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: This is a spontaneous report from a contactable consumer or other non hcp. A first dose of female patient of an unspecified age received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot number: not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. she had the Pfizer vaccine and it has not quite been 21 days since that dose. She stated her next dose if scheduled at 19 days after the first dose. She stated she takes a blood thinner for a-fib and stated this was Amlodipine. She stated she did not have any symptoms after her first dose other than a sore arm, which lasted 5 to 6 days, which was longer than her daughter. The caller stated she heard the second dose is more.She stated she heard people were dying from the second dose. She heard that what they put in the second dose is bad, like stuff from babies and that the dose is more than the first and that they aren't telling people what they put in it but it is bad. She wanted to know if the second dose was worse and if people died from it. The patient experienced her next dose if scheduled at 19 days after the first dose and sore arm. The outcome of the events was unknown. Information about batch/lot number has been requested Follow-up (14May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1791369
Sex: F
Age:
State: NY

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: diarrhea- not a formed stool or a mousse stool; she slept like 4 days after, she slept and slept; Pain in arm; This is a spontaneous report from a contactable consumer (patient's husband). A 79-years-old female patient received bnt162b2 (BNT162B2, formulation; solution for injection, lot number: EL9262), via an unspecified route of administration, administered in Arm Left on 04Feb2021 (at the age of 79 years) as dose 1, single for covid-19 immunization. Medical history included arthritis from an unknown date and unknown if ongoing (it is hard for his wife to walk due to this, she has a lot of it, and it was diagnosed a long time ago), diabetes from an unknown date and unknown if ongoing (this was diagnosed a long time ago), neuropathy from an unknown date and unknown if ongoing (this was diagnosed a long time ago). There were no concomitant medications. On an unspecified date, the patient experienced diarrhea- not a formed stool or a mousse stool, she slept like 4 days after, she slept and slept, pain in arm. Reporter said she had a form of diarrhea, she says not, reporter said there was no form to it, it just came out, it was not formed stool, and she has always had formed stool, now she had whatever you call it, reporter called it diarrhea. She was scheduled to take her second shot on Thursday, and they were concerned about the diarrhea since it was still going on, and she was always exhausted after the bowel movement. One other thing was his wife had pain in her arm after getting the shot that lasted about 4 days. They did no treatment for diarrhea, they were not sure if it was gonna be short time or what, also because it wasn't affecting anything. When patient first got the shot, she slept like 4 days after, she slept and slept, he had to get her up to make her eat, she slept an awful lot. There has been no treatments. Clinical outcome of the event was reported as unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791370
Sex: M
Age:
State: MA

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: little chills, and minor soreness; little chills, and minor soreness; got both the Pfizer and Moderna Covid-19 Vaccines; got both the Pfizer and Moderna Covid-19 Vaccines; This is a spontaneous report from a Contactable Consumer. A 77-Year-old male consumer reported that: Patient received (Pfizer-Biontech Covid-19 Vaccine, Formulation, solution for injection, Batch/lot number: Unknown, Expiry Date of Covid-19 Vaccine: Unknown) via unspecified route of administration in left arm on 20Feb2021 as dose 2, single (age at vaccination 77 years )for COVID-19 vaccination. The patient medical history and concomitant medication were not reported. Historical vaccine included Moderna Covid-19 Vaccine Batch/lot number: Unknown, Expiry Date of Covid-19 Vaccine: Unknown) on 30Jan2021 for COVID-19 vaccination. Patient received the 1st dose of the Moderna vaccine on 30Jan2021 and received the 2nd dose is from Pfizer on 20Feb2021. It was reported that patient was not experiencing side effects other than little chills, and minor soreness. Patient was asking if there had been reports about my situation and any potential side effects. The outcome of events were unknown No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791371
Sex: F
Age:
State: FL

Vax Date: 02/21/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: arm soreness; muscle soreness; general body aches; Headache/migraine; Headache/migraine; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 66-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: Not reported) via an unspecified route of administration, administered in arm on 21Feb2021 as dose 2, single for COVID-19 immunization. Action taken with drug was reported as unknown. The patient's medical history and concomitant medications were not reported. It was reported that she received her second Pfizer COVID vaccine dose 21Feb2021. She experienced arm soreness, muscle soreness, general body aches, and a headache after receiving the second dose. She took Excedrin migraine and tramadol to treat the symptoms. She wants to know if this was ok to do. Caller on the line calling about the vaccine, for the virus, clarified to be the COVID Vaccine. She stated she just had the second one yesterday on 21Feb2021. After the second one her arm was really sore. It continued to get worse as the evening went on. Then her muscles started to get sore and she got achy. She was calling to confirm if whatever she took after getting the second dose was okay. She stated she took a Excedrin Migraine because she also had a headache/migraine. Then after the middle of the night around 3-4 she could not sleep. She was sore so she took Tramadol. On an unspecified date in 2021 patient experienced arm soreness, muscle soreness, general body aches, headache/migraine. Seriousness of the events was reported as non serious. Therapeutic measures were taken as a result of the adverse events which included Excedrin migraine and tramadol. The outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791372
Sex: F
Age:
State: CT

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Head ache; Fatigue; Some nausea; This is a spontaneous report from a contactable consumer (patient). A 34-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL3247, Expiry date: not reported), via an unspecified route of administration in left arm on 19Feb2021 13:15 (at age of 34-years-old) as dose 2, single for covid-19 immunisation in workplace clinic. The patient medical history was not reported. The patient had no known allergies and had no allergies to medications, food, or other products. The patient previously took first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot number: EL3247, Expiration Date: Not reported), via an unspecified route of administration in left arm on 29Jan2021 13:15 as dose 1, single for covid-19 immunisation. Concomitant medication(s) included ibuprofen (IBUPROFEN) taken for an unspecified indication, start and stop date were not reported and multi vitamin. The patient was not pregnant at the time of vaccination. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. On 20Feb2021 at 06:00, the patient experienced headache, fatigue, some nausea. No therapeutic measures were taken in response to the events. The events recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1791373
Sex: F
Age:
State: CA

Vax Date: 01/22/2021
Onset Date: 02/02/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: pain in rotator cuff and back; sore throat; This is a spontaneous report from a contactable consumer (patient). A 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration, administered in arm left on 22Jan2021 (at the age of 81-years) as dose 1, single for covid-19 immunization. Patient medical history and concomitant medications were not reported. The patient had her first dose of the Pfizer Covid vaccine on 22Jan2021, states ten days later on 02Feb2021, had a sore throat, lasted about 8 days, had to take a Z-pack, not normal for her and states it went away around the 09Feb2021. States the patient got the second dose of the Pfizer Covid vaccine on 12Feb2021 and the patient got up Sunday morning, 21Feb2021, with a sore throat again, states it was worse today that it was when the patient woke up yesterday. The patient had a tear in her rotator cuff, started hurting her last week, got a corticosteroid injection in that area about 6 weeks ago prior to vaccine, states now arm was hurting and back was hurting and was unsure if it was related to the vaccine. The patient did had little spot about the size of a nickel after the vaccine where they gave the shot that was a little sore, whole arm was fine. when the patient gets a flu shot, she did not even move her arm for days. The patient did not go to the emergency room and physician office. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not had relevant tests. The patient received treatment for adverse event. The outcome of the event oropharyngeal pain was resolved on 09Feb2021 and outcome of the event pain extremity was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791374
Sex: F
Age:
State: ID

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: felt a sting when the needle went in to her arm; The liquid in the vial squirted out as the nurse was giving it to her and it ran down her arm; The liquid in the vial squirted out as the nurse was giving it to her and it ran down her arm; The liquid in the vial squirted out as the nurse was giving it to her and it ran down her arm; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), intramuscular in the right arm, on 19Feb2021 10:00 (Lot number: EL9267; Expiration date: 31May2021), at age 76 years old, as dose 1, single, for COVID-19 immunisation, at a public health department. The patient has no medical history and concomitant medications. The patient received her first dose of the Pfizer COVID-19 vaccine on Friday, 19Feb2021 10:00. She stated that the liquid in the vial squirted out as the nurse was giving it to her, and it ran down her arm. She stated that the nurse asked someone to report it, but the nurse told the patient just to come back for her second dose stating it should cover you. She reported that the nurse said, well that doesn't seem right, and then the nurse said, well that was fast. When the caller looked at her arm, the liquid was running down her arm. The nurse said it squirted out at her, so the patient has no idea how much she vaccine got. The patient wanted to know if it was safe to get the second dose if you did not receive the first dose and if it is important to get two full doses. Also, the patient felt a sting when the needle went in her arm. She felt the needle go in but felt nothing after that. The events did not require emergency room and physician's office visits. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791375
Sex: F
Age:
State: CA

Vax Date: 02/16/2021
Onset Date: 02/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EL9265) via an unspecified route of administration in arm right on 16Feb2021 (age at Vaccination 66 years) as dose 2, single for COVID-19 immunization. Medical history included palpitations (she had them for about 8 years now), hypothyroid and a nodule on her thyroid. She did not suffer from anxiety. With the palpitations, she get shaky, teeth chatters, she do cold packs, and breathing exercises. There concomitant medications were none. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EL8982) via an unspecified route of administration on 25Jan2021 (age at Vaccination 66 years) as dose 1, single for COVID-19 immunization. On 19Feb2021, the patient experienced nausea, pain at the injection site and increased palpitations. On an unspecified date, the patient experienced dizziness, weakness, headache, tiredness, lethargy, diarrhoea and dry mouth like she was dehydrated. She said that last night she was up until 5am with severe palpitations. She said that she has a nodule on her thyroid and is trying to rule everything out. She has a biopsy scheduled for next month. They gave her alprazolam 3 mg and she took it early and it did the trick. She was prescribed metoprolol. Therapeutic measures were taken as a result of nausea and increased palpitations. She took some Pepto Bismol. She said that 3 days after the injection she had increased palpitations, nausea, and pain at the injection site. The nausea subsided, but she reported that she also had dizziness, weakness, diarrhea, slight headache. She said that always has headaches though. She said that she also had tiredness and was lethargic. She said that her main concern was the palpitations. She also had dry mouth like she was dehydrated. She was wondering if it trigger something with her thyroid. On an unspecified date in 2021, the event nausea was recovered. The outcome of the other events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Palpitations

ID: 1791376
Sex: F
Age:
State: PA

Vax Date: 02/19/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: heart rate; Result Unstructured Data: Test Result:high; Test Name: oxygen; Result Unstructured Data: Test Result:83; Test Date: 202012; Test Name: Covid Rapid Test; Test Result: Positive ; Comments: nasal swab

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: sore arm; she has redness and a hard raised lump around the injection site; she has redness and a hard raised lump around the injection site; This is a spontaneous report from a contactable consumer or other non hcp (patient) via medical information team. A 61-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was reported as EL9266, Expiry date was not reported) on an unspecified route of administration, administered in arm right on 19Feb2021 (at the age of 61 years old) dose 1, single for COVID-19 immunisation. Medical history included diabetes from an unknown date and unknown if ongoing Hereditary Diabetic. Reporter reported that she had Covid around Dec2020 and she was in the hospital for 5 days, was on Remdesivir, steroids, insulin, and blood thinners. Concomitant medications included metformin taken for diabetes mellitus, start and stop date were not reported, Cinnamomum verum (CINNAMON) Capsule taken for diabetes mellitus, start and stop date were not reported, acetylsalicylic acid (BABY ASPIRIN) 81 mg taken for an unspecified indication, start and stop date were not reported; Multivitamin. Patient got her First Dose 19Feb2021 between 4-5 PM. On an unspecified date in Feb2021 the patient states she has redness and a hard raised lump around the injection site. Her arm was sore but that was okay, however it had got like a hard lump around it, she asks if it will go down, it about the size of a silver dollar, it is red and raised. On 20Feb2021 the patient experienced sore arm. The reporter stated her husband put a circle around her, and that is when she saw the size. It being a hard lump was noticed Sunday. The lump has gone down, but it is a weird hard. The patient underwent lab tests and procedures which included heart rate which was high on unspecified date; Oxygen (Oxygen saturation) Result as 83 on unspecified date, Covid Rapid Test (SARS-CoV-2 test) result as positive nasal swab on Dec2020. Patient has had no covid tests since then. The outcome for the event sore arm, she has redness was unknown and for the event she has redness and a hard raised lump around the injection site was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds: METFORMIN; CINNAMON; BABY ASPIRIN

Current Illness:

ID: 1791377
Sex: F
Age:
State: SC

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202012; Test Name: Covid; Result Unstructured Data: Test Result:mild

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Lightheadedness; Shaking really bad and was frozen; Shaking really bad and was frozen; Headache; Sore arm; Wasn't feeling good; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6201; Expiration Date: 30Jun2021) via an unspecified route of administration, administered in left arm on 21Feb2021 (age at vaccination 81 years) as DOSE 2, 0.3 ML SINGLE for COVID-19 immunisation. Medical history included ongoing essential tremors (started in her twenties), shoulder replacement; left shoulder two years ago and right shoulder ten years ago and mild Covid in Dec2020. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: not reported, Expiration Date: 30May2021) via an unspecified route of administration, administered in right arm, on 31Jan2021 as DOSE 1, SINGLE, for COVID-19 immunisation The patient's concomitant medications were not reported. The patient reported that after receiving the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine yesterday, she experienced some side effects. On 21Feb2021 22:30 she was shaking really bad, and was frozen She also had headache, sore arms. She also mentioned that on her card, she saw a sticker with the expiration date, 30Jun2021. The patient wanted to know if this was the expiration date for the vaccine, and if she needs to take another dose of the vaccine after the vaccine expires. She read all the information. She was fine until bedtime. She went to bed early because she was not feeling good. She woke at 10:30pm and was shaking so bad and was frozen. She keeps the heat at 70. She turned it up to 72 degrees and had two sweaters on and she was still cold. She guesses that was to be expected. She also had a headache and a sore arm. She was lightheaded this morning on 22Feb2021. She guesses that goes with it. Therapeutic measures were taken as a result of shaking really bad and was frozen. Outcome of the events Light-headedness recovered on 22Feb2021, event of not feeling good was unknown and other events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness: Tremor (Patient history: essential tremors (From: Unknown To: Ongoing))

ID: 1791378
Sex: M
Age:
State: NC

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Diarrhea; Dizziness; This is a spontaneous report from a contactable consumer (Patient). A 73-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EN6201) intramuscular, administered in left arm on 21Feb2021 09:00 (at the age of 73-year-old) as dose2, single for COVID-19 immunization. Medical history included stroke since 2012. The patient's concomitant medications were not reported. The patient received first dose of bnt162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE solution for injection, Lot: EL9263, Expiry: unknown) intramuscular, administered in left arm on 29Jan2021 (at the age of 73-year-old) for COVID 19 Immunization. The patient did not had any additional vaccines administered on same date of the Pfizer Suspect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Feb2021, the patient experienced dizziness and diarrhoea. The patient experienced some dizziness last night that he reports was much better on the day of report. The patient reported that he had the shot yesterday morning (21Feb2021) and by last night around 10 or 11pm, he experienced dizziness. The dizziness lasted through the night sometime and by this morning it has subsided quite a bit. He felt some slight dizziness but nothing like it was last night. The patient also had a small occurrence of diarrhea during the day yesterday, probably around 10 am (an hour after receiving the shot). Vaccination Facility Type was reported as Clinic. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available). The patient confirmed that it was just one occurrence of diarrhea. The adverse events did not require a visit to emergency room and physician office. The clinical outcome of dizziness was resolving and diarrhoea was resolved on 21Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791379
Sex: F
Age:
State: AL

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: blood work; Result Unstructured Data: Test Result:Unknown

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Sore arm; Feel a little punky in my head and light headed; Dizzy sort of like my brain is pause; brain feels fuzzy; dizziness; light headedness; This is a spontaneous report from a contactable consumer or other non hcp. A 70-years-old female patient received bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN5318; Expiration Date: May2021), via intramuscular route, administered in Arm Left on 20Feb2021 09:00 as DOSE 1, SINGLE for COVID-19 immunisation. Medical history included hypertension, blood cholesterol, gastro oesophageal reflux disease, anxiety, depression, and sleep disorder. Concomitant medication(s) included indapamide (INDAPAMIDE) taken for hypertension, atorvastatin (ATORVASTATIN) taken for blood cholesterol, omeprazole (PROTONIX [OMEPRAZOLE]) taken for gastro oesophageal reflux disease, alprazolam (XANAX) taken for anxiety, escitalopram oxalate (LEXAPRO) taken for depression and amitriptyline (AMITRIPTYLINE) taken for sleep disorder. The patient previously took erythromycin for drug hypersensitivity. On 20Feb2021 09:00 the patient experienced dizziness, light headedness, and dizzy sort of like her brain was paused. On an unspecified date patient developed sore arm and felt a little punky in her head and lightheaded. The patient underwent lab tests and procedures which included blood test: unknown. The event outcome for dizziness, light headedness, and dizzy sort of like her brain was paused was reported as not recovered. The events outcome for sore arm and felt a little punky in her head and lightheaded was reported as unknown. No follow-up attempts are needed. No further information is expected.

Other Meds: INDAPAMIDE; ATORVASTATIN; PROTONIX [OMEPRAZOLE]; XANAX; LEXAPRO; AMITRIPTYLINE

Current Illness:

ID: 1791380
Sex: F
Age:
State: CA

Vax Date: 02/13/2021
Onset Date: 02/14/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Name: Height; Result Unstructured Data: Test Result:Provided both 5 feet 3 inches and 5 feet 4 inches

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Body wasn't regulating temperature; unsettled stomach; Overall tired and fatigue; Aching; Feeling unwell; Aching in legs; arm soreness was in the right arm, which was the injection arm; This is a spontaneous report from a contactable consumer (Patient). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: C13248), via an unspecified route of administration, administered in Arm Right on 13Feb2021 (at the age of 74-years old) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included hypertension , ventricular tachycardia, blood cholesterol abnormal. Concomitant medication included lisinopril (LISINOPRIL) taken for hypertension, atenolol (ATENOLOL) taken for ventricular tachycardia, simvastatin (SIMVASTATIN) taken for blood cholesterol abnormal. Patient received her first dose of Pfizer-Biontech Covid-19 vaccine 13Feb2021 and reports AEs starting on 19Feb2021. Her symptoms include unsettled stomach, overall tired and fatigued, aching, body just wasn't regulating its temperature She was hot and then cold, no fever reported, started feeling unwell, aching in legs, and just unwell. It has been on and off over the weekend. arm soreness was in the right arm, which was the injection arm. Patient was feeling a little better on Saturday, but still kind of off. Yesterday she was feeling kind of off. It is hard to tell how she is feeling today because she just got up. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; ATENOLOL; SIMVASTATIN

Current Illness:

ID: 1791381
Sex: M
Age:
State: NY

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result:170/95; Comments: elevated; Test Name: Blood pressure; Result Unstructured Data: Test Result:183/95; Test Name: Blood pressure; Result Unstructured Data: Test Result:173/94; Test Name: Blood pressure; Result Unstructured Data: Test Result:187/97; Test Name: Blood pressure; Result Unstructured Data: Test Result:163/93; Test Date: 20210222; Test Name: Blood pressure; Result Unstructured Data: Test Result:151/89; Test Date: 20210222; Test Name: Blood pressure; Result Unstructured Data: Test Result:138/80

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: blood pressure became elevated /blood pressure has been up; This is a spontaneous report from a contactable consumer. This consumer reported for male patient (husband): A 87-year-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- Unknown) via intramuscularly, in right arm on 03Feb2021 10:00 as dose 1, single (at the age of 86-years-old) for COVID-19 immunization. The patient medical history included rheumatoid arthritis, thyroid, pain and blood pressure. The concomitant medication of the patient included losartan and amlodipine besylate both for blood pressure, levothyroxine sodium (SYNTHROID) for thyroid and tramadol for pain. On an unspecified date the patient experienced blood pressure became elevated /blood pressure has been up. Reporter stated that patient (reporters husband) after receiving the 1st dose, patient blood pressure became elevated. Reporter noticed that the ingredients of the vaccine contain sodium chloride, and dibasic sodium phosphate dihydrate. Reporter queried if these contain salt. Reporter queried if Pfizer-BioNTech Covid-19 Vaccine would work on immunocompromised patients, specifically for those who have rheumatoid arthritis. Reporter stated that she started to notice an increase in his blood pressure of patient more or less the last 2 weeks. On an unspecified date the patient underwent lab tests and procedures which included patient blood pressure readings have been 170/95 (elevated), 183/95, 173/94, 187/97 and 163/93. On 22Feb2021 the patient blood pressure at 2:30 pm and it was 151/89 and at 3:15pm, it was 138/80. Reporter stated that patient was receiving treatment of losartan 100 mg, tablet, by mouth, once a day, Amlodipine besylate 2.5 mg tablet, by mouth, once a day in the morning for the blood pressure. Reporter also mention that patient was taking arthritis medicine, synthroid for thyroid and also tramadol 50mg tablet, by mouth, twice a day for pain. Reporter stated that patient was been on all of these medications for more than 2 weeks prior to receiving the vaccine. Outcome of the reported events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: LOSARTAN; AMLODIPINE BESYLATE; SYNTHROID; TRAMADOL

Current Illness:

ID: 1791382
Sex: M
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Headache on the following day; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 50-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection; #lot: EL3247) via an unspecified route of administration, administered in left arm on 19Feb2021 09:30 AM (at the age of 50-years-old) as dose 2, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. No other vaccine administered within 4 weeks from vaccination. Patient not diagnosed with covid prior vaccination and not tested for covid post vaccination. On 20Feb2021, the patient experienced headache on the following day. No treatment received for the event. The outcome of the event was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791383
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: toothache; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (BNT162B2 Formulation; solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had a toothache on an unspecified date. The patient scheduled for the second dose of COVID 19 Vaccine tomorrow (21Feb2021) and she asked if Advil could take before the vaccine. The outcome of event was unknown. No follow-up attempts are possible; Information on lot number, batch number could not be obtained.

Other Meds:

Current Illness:

ID: 1791384
Sex: M
Age:
State: NJ

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Slight pain in the left arm where vaccine was given i; This is a spontaneous report from a contactable consumer (Patient) or other non-HCP. A 61-years-old male received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, on 22Feb2021 at 11:30 (age at the time of vaccination was 61-years-old) as DOSE 1, SINGLE dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no other vaccines in 4 weeks and no other medications in 2 weeks. The patient did not have COVID-19 prior to vaccination and was not been tested for COVID-19 post the vaccination. On 22Feb2021 (at 20:00), the patient experienced Slight pain in the left arm where vaccine was given i. The clinical outcome of the event was not recovered. Follow-up (14May2021): Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1791385
Sex: F
Age:
State: MO

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: sore arm at site of injection; Fatigue; Body aches; This is a spontaneous report from a contactable consumer. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, in the left arm, on 17Feb2021 (Lot number not reported), at age 54 years old, as dose 2, single, for COVID-19 immunisation, at a public health department. The patient was not pregnant at the time of vaccination. Relevant medical history included high blood pressure, controlled from an unknown date, not reported if ongoing or not. The patient has no allergies to medications, foot or other products. Concomitant medications included spironolactone and venlafaxine both taken for unknown indications, start and stop date not reported. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection) administered in the left arm, on 27Jan2021 (Lot number not reported), at age 54 years old, as dose 1, single, for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 18Feb2021 07:00, the patient experienced sore arm at site of injection, fatigue and body aches. No treatment was given for the events. The patient recovered from the events on an unspecified date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SPIRONOLACTONE; VENLAFAXINE

Current Illness:

ID: 1791386
Sex: F
Age:
State: NJ

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Some soreness in left arm where the injection was made; This is a spontaneous report from a contactable consumer (patient). A 59-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL3247), via an unspecified route of administration, administered in arm left on 22Feb2021 12:00 (at the age of 59-years-old) as dose 1, single for covid-19 immunisation. The vaccine was administered at the workplace clinic. The patient medical history included diabetes, high blood pressure, reflux. The patient also had allergy to Penicillin. Concomitant medications included metformin; dulaglutide (TRULICITY); empagliflozin (JARDIANCE); esomeprazole magnesium (ESOMEPRA); and atorvastatin (LIPITOR [ATORVASTATIN]) taken for an unspecified indication, start and stop date were not reported. The patient experienced some soreness in left arm where the injection was made on 22Feb2021 15:00 with outcome of recovered the next day, 23Feb2021 with no treatment was received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.

Other Meds: METFORMIN; TRULICITY; JARDIANCE; ESOMEPRA; LIPITOR [ATORVASTATIN]

Current Illness:

ID: 1791387
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: little bit achy and achiness type stuff; normal low energy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number was not reported) on an unspecified date as first dose for covid-19 immunisation. On an unspecified date, the patient experienced little bit achy, and the achiness type stuff, and had normal low energy. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791388
Sex: F
Age:
State:

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in the left arm on 22Feb2021 at 15:15 (age at the time of vaccination was 49-year-old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient reported no allergies to medications, food, or other products. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced pain at injection site on 22Feb2021 at 15:30. Patient did not receive any treatment to the event. Patient was not diagnosed with Covid-19 prior to vaccination and not tested for covid since vaccination. The outcome was recovered with sequelae for the event. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791389
Sex: F
Age:
State: WY

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Debilitating migraine; This is a spontaneous report from a contactable consumer (patient). A 31-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 20Feb2021 10:00 as DOSE 1, SINGLE for covid-19 immunization at the age of 31-year-old. The patient was not pregnant at time of vaccination. Patient denied for any medical history. The patient had no known allergies. Patient denied for any other vaccine in four weeks and denied for any other medications in two weeks. Patient did not had covid prior to vaccination neither tested for covid post the vaccination. The patient's concomitant medications were not reported. On 20Feb2021 at 20:00, the patient experienced debilitating migraine. The patient did not receive any treatment for the event. The reporter considered the event as non-serious. The outcome of event was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791390
Sex: M
Age:
State: NJ

Vax Date: 02/05/2021
Onset Date: 02/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20200721; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Fatigue and muscle soreness in upper legs lasting 10-14 days. Severe respiratory phlegm white mucus lasting 1 week. Next dose is Feb26 at 3pm. Wondering if I should proceed?; Fatigue and muscle soreness in upper legs lasting 10-14 days. Severe respiratory phlegm white mucus lasting 1 week. Next dose is Feb26 at 3pm. Wondering if I should proceed?; Fatigue and muscle soreness in upper legs lasting 10-14 days. Severe respiratory phlegm white mucus lasting 1 week. Next dose is Feb26 at 3pm. Wondering if I should proceed?; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional. A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on 05Feb2021 at 15:30 (at the age of 65-year-old), in Arm Left, as dose 2, single for COVID-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing. Patient known allergies reported as ?NO'. Concomitant medication(s) included ALA ALC, vitamin D, magnesium, Vitamin C, Amlodipine taken for an unspecified indication, start and stop date were not reported. Historical vaccine of patient included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration, on unspecified date (at the age of 65-year-old), as dose 1, single for COVID-19 immunization. Patient did not took any other vaccine within four weeks of COVID vaccine. Patient had not tested COVID prior vaccination and had been tested COVID test post vaccination. On 08Feb2021 08:00 the patient experienced fatigue and muscle soreness in upper legs lasting 10-14 days. severe respiratory phlegm white mucus lasting 1 week. next dose is feb26 at 3pm. wondering if i should proceed. On 21Jul2020 the patient underwent lab tests and procedures which included sars-cov-2 test: negative. Patient visited Doctor or other healthcare professional office(or) clinic visit as a result of AE. Treatment was not received. The clinical outcome of events was recovering. Follow-up attempts completed. No further information expected.

Other Meds: ALA [THIOCTIC ACID]; VITAMIN D [VITAMIN D NOS]; MAGNESIUM; VITAMIN C [ASCORBIC ACID]; AMLODIPINE

Current Illness:

ID: 1791391
Sex: F
Age:
State: NJ

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: BMI; Result Unstructured Data: Test Result:35.5

Allergies:

Symptom List: Nausea

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 41-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9266 and expiry date was not reported), via an unspecified route of administration, in Arm left on 22Feb2021 at 17:30 (Age at vaccination: 41 years old) as dose 1, single for COVID-19 immunization. The patient medical history included BMI: 35.5, allergies to Penicillins and history of current asthma (ongoing). Concomitant medications included ibuprofen (ADVIL 12 HOUR), received 4 days before vaccine and daily PROBIOTICS. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. On 22Feb2021 at 19:00 (night), the patient had Soreness at injection site (severity: mild and no medications required). The patient was scheduled for a second dose date 18 days after first dose (of less than 21 days). The patient didn't realize they had scheduled her for an earlier date until she left the vaccination site, and she cannot find any way to correct this. The case was considered as non-serious. The patient did not receive any treatment for the event. Outcome of the event was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: ADVIL 12 HOUR

Current Illness: Asthma

ID: 1791392
Sex: M
Age:
State: MA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: This is a spontaneous report from a contactable physician (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL3247, Expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:30 (age at vaccination: 65-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history included treated hypertension. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 22Feb2021, at 19:00, the patient experienced grade 1 severity soreness at site of vaccination following injection. Improved in severity by next day. No interference with activity, no analgesics required. No treatment was received for the adverse event. The outcome of the event was recovering. No Follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791393
Sex: F
Age:
State: MA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body aches; Extreme body chills; Rash at injection site; This is a spontaneous report from a contactable other health professional (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EN6200) via an unspecified route of administration, administered in arm left on 22Feb2021 12:00 (age at the time of vaccination was 27 years) as dose 2, single for COVID-19 immunisation at a health clinic. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. There were no known allergies. There was no other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient not been tested for COVID-19. The patient's concomitant medications included Vitamin D3, calcium carbonate/ calcium gluconate/ magnesium gluconate/ magnesium oxide/ zinc citrate/ zinc oxide (CALCIUM MAGNESIUM AND ZINC) and probiotic, all drugs received within 2 weeks of vaccination. The patient took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, lot number: EL9264) via an unspecified route of administration, administered in left arm on 03Feb2021 13:15 (age at the time of vaccination was 27 years) as dose 1, single for covid-19 immunisation at school or student health clinic. On 22Feb2021, at 22:30, the patient had body aches, extreme body chills and rash at injection site after injection. The patient was not received treatment for adverse events. The outcome of events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: VITAMIN D3; CALCIUM MAGNESIUM AND ZINC

Current Illness:

ID: 1791394
Sex: F
Age:
State: MA

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Left deltoid pain - inhibiting range of motion and function; Left deltoid pain - inhibiting range of motion and function; Headache; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female non pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in Arm Left on 22Feb2021 09:30 (at the age of: 45-years-old) as dose 1, single for covid-19 immunization. Medical history included sulfa allergies. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine with in 4 weeks prior to the covid vaccination. List of any other medications the patient received within 2 weeks of vaccination was reported as None. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Feb2021 12:00 the patient experienced left deltoid pain- inhibiting range of motion and function and headache. The patient did not receive any other treatment as a result of events. The outcome of the events was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791395
Sex: M
Age:
State: CT

Vax Date: 02/22/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Headache; Sore arm; General unwellness; This is a spontaneous report from a contactable consumer. This contactable 60-year male patient consumer reported that: A 60-years-old male patient received (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, lot number: EL 3247) via an unspecified route of administration in arm left on 22Feb2021 10:00 am (at the age of 60 years) as dose 1, single for COVID-19 immunisation (workplace clinic). Medical history was not reported. Allergies to medications, food, or other products: no. Concomitant medication was not reported. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. On 22Feb2021 at 14:00 patient experienced headache, sore arm and general unwellness. Upon follow up (02Mar2021) report received in response to the mail trail sent regarding the confirmation of awareness date response: 22Feb2021. Patient didn't received treatment for events. The outcome of events was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1791396
Sex: F
Age:
State: MA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Chills; Fatigue; This is a spontaneous report from a contactable consumer (Patient) via Regulatory Authority A 77-year-old female patient (non-pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: Not reported) via an unspecified route of administration on 01Feb2021 (at the age of 77-year-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient medical history included thyroid disease, high cholesterol and (COPD) chronic obstructive pulmonary disease). No known allergies to medications, food, or other products. Concomitant medication included rosuvastatin and levothyroxine (within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced chills and fatigue on 01Feb2021. Patient did not receive any treatment as a result of events. The outcome of the events was resolved on an unspecified date in 2021. No follow-up attempts are needed. Information about lot/batch numbers cannot obtained.

Other Meds: ROSUVASTATIN; LEVOTHYROXINE

Current Illness:

ID: 1791397
Sex: F
Age:
State: FL

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Head ache; sore arm; This is a spontaneous report from a contactable consumer (patient). A 65-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 30Jan2021 (at the of 65-year-old) as dose 1, single and second dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 20Feb2021 (at the of 65-year-old) as dose 2, single for COVID-19 immunization. Medical history included chronic obstructive pulmonary disease. The patient's concomitant medications were not reported. Allergies to medications, food, or other products were reported as no. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Additional vaccines administered on same date of the Pfizer Suspect was reported as none. On 30Jan2021 the patient experienced head ache, sore arm. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient was not tested for COVID-19. Patient not received any treatment for the events. Outcome of the events was recovered on unknown date in 2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1791398
Sex: M
Age:
State: FL

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Head ache sore arm for about a day; Head ache sore arm for about a day; This is a spontaneous report from a non-contactable consumer (patient) or other non-health care professional. A 67-year-old male patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 20Feb2021 (at the age of 67-year-old) as dose 2, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease from an unknown date and unknown if ongoing. Patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. Historical vaccine included BNT162B2 (solution for injection, Batch/Lot Number: Unknown) via an unspecified route of administration, administered on 30Jan2021 as dose 1 single for COVID-19 immunization. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient had been not tested for COVID-19 since the vaccination. On 20Feb2021 the patient experienced head ache sore arm for about a day. No treatment received for the events. Outcome of the events resolved on an unspecified date in Feb2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1791399
Sex: M
Age:
State: CO

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Ringing in ear; This is a spontaneous report received from a contactable other hcp (Nurse). A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EM9810) intramuscular on 08Feb2021 (at the age of 65-year-old) as dose 1, single for COVID-19 immunization. Medical history included BPH (benign prostatic hyperplasia), OSA (Obstructive sleep apnea syndrome), Hyperlipidemia, known allergies: Sulfa and Finasteride. The patient previously took finasteride and experienced drug hypersensitivity. Patient did not receive any other vaccines in four weeks. Patient received other medications in two weeks. Patient was not diagnosed with COVID-19 prior to vaccination and since vaccination patient has not been tested for COVID-19. On 08Feb2021 (started 5 hours after vaccine), the patient experienced ringing in ear, lasted for more than 8 days. Patient did not receive any treatment for event. Outcome of event was unknown. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1791400
Sex: U
Age:
State: PA

Vax Date: 02/18/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: My arm hurt last night and this morning; This is a spontaneous report from a contactable consumer(patient). A 44-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247; Expiration Date: May2021, at the age of 44 years), dose 1 intramuscular, administered in Arm Left on 18Feb2021 10:30 as dose 1, single for covid-19 immunisation at workplace clinic. The medical history and concomitant medications were not reported. No Prior Vaccinations administered. The patient reported left arm hurt last night and that morning on 18Feb2021 17:00 but it was improving. The event did not require the initiation of new medication/ other treatment/ procedure. The outcome of the event was recovered on 19Feb2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791401
Sex: F
Age:
State: NY

Vax Date: 02/20/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Extreme headache; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 9269) via an unspecified route of administration in the arm left on 20Feb2021 at 11:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, high cholesterol and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included olmesartan medoxomil (BENICAR), venlafaxine hydrochloride (EFFEXOR), atorvastatin calcium (LIPITOR), trazodone hydrochloride (TRAZADONE), menthol, capsaicin (ALLEVE) and Motr all for unknown indication from an unknown date and unknown if ongoing. On 22Feb2021, the patient experienced extreme headache. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extreme headache was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BENICAR; EFFEXOR; LIPITOR; DEPRAX [TRAZODONE HYDROCHLORIDE]; ALLEVESS

Current Illness:

ID: 1791402
Sex: F
Age:
State:

Vax Date: 02/17/2021
Onset Date: 02/18/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Nausea; Headache; Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the arm right on 17Feb2021 at 15:45 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome(IBS), soy allergy and allergy to sulfa drugs. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (MANUFACTURER UNKNOWN) taken for unknown indication from unknown date and unknown if ongoing. The patient previously took codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. On 18Feb2021 at 05:00, the patient experienced nausea, headache and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, headache and diarrhea was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SERTRALINE HYDROCHLORIDE

Current Illness:

ID: 1791403
Sex: F
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: chills; difficult to sleep; headache; pain+soreness in my left arm (injection site); pain+soreness in my left arm (injection site); This is a spontaneous report from a non-contactable consumer (herself). A 26-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL3247, Expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 19Feb2021 at 09:30 (Age at vaccination 26-years-old) as dose 2, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number: EL3247, Expiry date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 09:15 as dose 1, single for covid-19 immunisation. On 19Feb2021 11:30, the patient experienced about 2 hours after 2nd dose of vaccine, noticed a headache that was gradually increasing and pain + soreness in my left arm (injection site) became apparent. No treatment was taken, the side effects are manageable without medications. About 18-20 hours after my 2nd vaccine dose (20Feb2021), noticed headaches that lasted through the night which made it difficult to sleep, in addition to chills. This lasted about 6-8 hours and then had subsided. Also, I woke up with pain at the injection site and muscle soreness but has since gotten better. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the events. The clinical outcome of the events was recovered on an unspecified date 2021. No follow-up attempts are possible. No further Information is expected.

Other Meds:

Current Illness:

ID: 1791404
Sex: F
Age:
State: IL

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Dizzy spells around 23 hours after the vaccine until about 27 hours after the vaccine; Sweats; chills from about 12 hours after the vaccine until about 36 hours after; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EC9265) via an unspecified route of administration in the right arm on 23Feb2021 at 14:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included birth control pill and montelukast sodium (SINGULAIR) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EC3249) via an unspecified route of administration in the right arm on 02Feb2021 at 14:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 24Feb2021 at 02:00, the patient experienced sweats and chills from about 12 hours after the vaccine until about 36 hours after and on 24Feb2021 at 13:00, experienced dizzy spells around 23 hours after the vaccine until about 27 hours after the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizzy spells was recovered on 24Feb2021 (about 27 hours after the vaccine) while the events sweats and chills were recovered on 25Feb2021 (about 36 hours after). No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR

Current Illness:

ID: 1791405
Sex: F
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Migraine; Headache; This is a spontaneous report from a contactable consumer (patient) received from a female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. The patient's medication history and concomitant medication were not reported. After receiving the first dose of bnt162b2, the patient experienced migraine and headache. The patient would like to delay getting the second dose instead of getting it on 10Mar2021 and she would like to get it on 12Mar2021. The outcome of migraine and headache was unknown. No follow-up attempts are required; information about lot/batch number cannot be obtained.No further information is expected.

Other Meds:

Current Illness:

ID: 1791406
Sex: F
Age:
State: AZ

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Soreness at injection site; This is a spontaneous report from a non-contactable consumer. A 77-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021(at the age of 77-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, GERD (gastroesophageal reflux disease) and allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 25Feb2021, the patient experienced soreness at injection site. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event soreness at injection site was recovering at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1791407
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This is a spontaneous report from a noncontactable healthcare professional. A 54-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6203), at the age of 54, via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. On an unknown date (during her 15 minutes waiting period after the injection), patient experienced mouth dryness. Therapeutic measures taken as a result of mouth dryness included treatment with antihistamines and water. Follow-up response to treatment was good. The patient was stable to go home when discharged. She was advised follow-up with primary care physician. The outcome of the mouth dryness: unknown (at the time of this report). No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1791408
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: lightheadedness; feeling weak; This is a spontaneous report from a non-contactable other healthcare professional. A 43-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration on an unknown date (at the age of 43-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date, during 15 minutes waiting period after the vaccination, the patient experienced light-headedness and felt weak. Therapeutic measures taken as a result of the reported events included water and snacks. It was reported that patient responded good to follow up treatment and the patient was stable to go to home and was asked to follow up with primary care physician (PCP). The differential diagnosis was reported as vaccine related anxiety (included misc mental health, as reported). The clinical outcome of events light-headedness and feeling weak was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791409
Sex: F
Age:
State: AZ

Vax Date: 02/17/2021
Onset Date: 02/22/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Feb2021 at 14:45 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer from an unknown date in 2005 and allergy to penicillin and sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included irbesartan (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and Vitamin (MANUFACTURER UNKNOWN); all for an unspecified indication from unknown date and unknown if ongoing. On 22Feb2021 monday at 02:30, the patient woke up with vertigo which she never had before. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vertigo was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: IRBESARTAN; VENLAFAXINE; CALCIUM

Current Illness:

ID: 1791410
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/25/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 24Feb2021 at 17:30 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included wheat allergy, corn allergy, chocolate allergy and tomatoes allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269) via an unspecified route of administration in the left arm on 23Feb2021 at 18:45 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. On 25Feb2021 at 05:00, the patient experienced severe headache, body aches, chills and sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe headache, body aches, chills and sore throat were unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1791411
Sex: F
Age:
State: CA

Vax Date:
Onset Date: 02/20/2021
Rec V Date: 10/16/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: swollen lymph node 3-7 days after injection; This is a spontaneous report from a contactable consumer. A 27-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN5318) via an unspecified route of administration, administered in Arm Left on an unspecified date (age at vaccination 27-years-old) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. On 20Feb2021, patient experienced swollen lymph node 3-7 days after injection. No treatment received for the AE. Patient has no Allergies to medications, food, or other products and patient has stated that she had not been diagnosed with COVID -19 prior to vaccination and not been tested since the vaccination. Outcome of the event was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am